Orion Biotech Opportunities - Warrants (15/04/2025) Common Stock

As of the most recent data (December 2022), ORIAW shows a common stock of $200M. That compares with $400M in the prior-year period — down 49.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ORIAW's common stock is now $200M (was $400M) — a 49.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Orion Biotech Opportunities - Warrants (15/04/2025) is outperforming or lagging.

Tracking ORIAW's common stock over time shows whether Orion Biotech Opportunities - Warrants (15/04/2025) is scaling, shrinking, or reshaping that part of the business. The current reading is $200M That compares with $400M in the prior-year period — down 49.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Orion Biotech Opportunities - Warrants (15/04/2025)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $200M) with ownership activity and broader fundamentals.